Form 4: Director Paul Burton Receives CDIO Stock Options

Director Paul Frederick Burton was granted 3,205 stock options in Cardio Diagnostics Holdings, Inc. on March 31, 2026.

Summary

• Director Paul Frederick Burton acquired 3,205 stock options in Cardio Diagnostics Holdings, Inc. (CDIO).
• The options have an exercise price of $1.95 per share.
• The options became exercisable on March 31, 2026, and expire on March 31, 2036.
• Following this transaction, the reporting person holds a total of 10,464 derivative securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on the company's financial outlook.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Minor dilution impact on existing shareholders, though the volume is negligible.

Risks

• The value of the granted options is dependent on the future market performance of CDIO common stock.

Future Outlook

The filing does not provide forward-looking guidance regarding company operations or financial performance.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize leadership and align interests with shareholders in the biotechnology and diagnostics sector.

Comparison to Industry Standards

• The grant of stock options to directors is a common practice among small-cap healthcare companies to preserve cash while providing competitive compensation packages.

Stakeholder Impact

• Minimal impact on shareholders due to the small size of the option grant.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

CDIO, Cardio Diagnostics Holdings, Form 4, Insider Trading, Stock Options, Director Compensation